Dedet J P, Melogno R, Cardenas F, Valda L, David C, Fernandez V, Torrez M E, Dimier-David L, Lyevre P, Villareal M E
Instituto Boliviano de Biologia de Altura, La Paz.
Bull World Health Organ. 1995;73(3):339-45.
Mucocutaneous leishmaniasis (MCL) is endemic in the tropical Amazonian lowlands of Bolivia, an area that regularly receives influxes of migratory populations. In these new agricultural development areas, a campaign to diagnose and treat the disease was carried out between 1989 and 1992, in order to provide direct access to MCL treatment in the endemic areas at a standard equivalent to that offered in the urban centres in Bolivia. The campaign led to the creation of decentralized local centres for diagnosis and treatment of the disease. A campaign to inform the population about leishmaniasis was also undertaken and courses were run to educate medical and paramedical personnel. As a result of the campaign, 3285 cases of leishmaniasis were diagnosed, including 2152 cutaneous and 326 mucosal forms. Also, a total of 1888 cases were treated, 1677 of which cutaneous and 211, mucosal.
皮肤黏膜利什曼病(MCL)在玻利维亚热带亚马孙低地流行,该地区经常有移民涌入。在这些新的农业开发区,1989年至1992年间开展了一项疾病诊断和治疗运动,以便在流行地区以与玻利维亚城市中心相同的标准直接提供MCL治疗。该运动促成了分散的地方疾病诊断和治疗中心的设立。还开展了一项向民众宣传利什曼病的运动,并举办了培训课程以教育医务人员和辅助医务人员。由于该运动,共诊断出3285例利什曼病病例,包括2152例皮肤型和326例黏膜型。此外,共治疗了1888例病例,其中1677例为皮肤型,211例为黏膜型。